Status:
COMPLETED
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis is a current infection during anti TNF therapy. After infectious contact, some patients will develop tuberculosis and some will only be infected without symptoms, they have Latent Tubercu...
Detailed Description
Detailed description : Principal outcome: Therapeutic impact of the use of new tests for diagnosis of LTBI in patients before anti TBF therapy Secondary outcomes : * medico-economic impact of repla...
Eligibility Criteria
Inclusion
- 18 years old
- Patient with rheumatoid arthritis or Ankylosing spondylitis or Crohn's disease
- Patient without Anti TNF treatment and who need one by infliximab, adalimumab or etanercept
- Consent signed
- Patient with social right
- Patient who have been examined
Exclusion
- Pregnancy and breast feeding
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT00811343
Start Date
December 1 2008
End Date
June 1 2012
Last Update
January 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bicêtre hospital
Le Kremlin-Bicêtre, France, 94275